Cambridge Healthtech Institute’s 6th Annual

AI/Machine Learning for Early Drug Discovery – Part 2

Generative AI & Predictive Algorithms for Small Molecule & Peptide Therapeutics

APRIL 3 - 4, 2024

Artificial Intelligence (AI)/Machine Learning (ML) for Early Drug Discovery is a two-part conference that brings together a diverse group of experts from chemistry, target discovery, pharmacology and bioinformatics, to talk about the increasing use of computational tools, models, algorithms and data analytics for drug development. The talks will highlight the pros and cons of AI/ML-driven decision-making using relevant case studies from small molecule and peptide drug development. The second part of this conference will focus on emerging computational tools and models to identify new drug targets, predict PK/PD and safety issues in drug candidates, and to drive niche applications in drug discovery.